IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Theravance Biopharma Inc

CUSIP: SBMNDK095 | 1 institutional holders

Quarters

Q1 2023Q2 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2023

Metropolitan Life Insurance Co3,472
0.0% of portfolio›$37.7K
StyleTurnoverLocationFiled
Metropolitan Life Insurance Co
3,472$37.7K0.0%ETFVery LowNew York, NY2023-05-15